INTERACTIVE PANEL DISCUSSION: Immune Check Point Inhibitor Combination Therapies: Where Does the Microbiome Stand?
Date & Time
Wednesday, June 3, 2020, 10:40 AM - 11:15 AM
Assaf Oron Mike Romanos Johan van Hylckama Vlieg Morten Isaksen

With big pharma investing in a verity of immune checkpoint inhibitor combination therapies (oncolytic viruses, combinations of checkpoint inhibitors, microbiome-based therapies) where does the microbiome stand vs other combo therapy types and what does the microbiome industry need to do to ‘win’ this battle vs other combo therapy types?

Session Type
Virtual Session Link
Session Themes
Microbiome in Oncology
On Demand